GlassScriptPhysician profile
Stephanie Wade
NPI 1396942736
$1,044.12
in general payments reported to CMS, 2019-2025
23 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $435 · 2022: $126 · 2023: $144 · 2024: $155 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $179.21 | 2021 | |
| Abbvie INC. | $122.82 | 2021-2023 | |
| Astellas Pharma US INC | $102.01 | 2023-2025 | Veozah |
| Lilly USA, LLC | $83.32 | 2021-2025 | Zepbound, Mounjaro |
| Dexcom, INC. | $80.74 | 2024-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $67.76 | 2021-2024 | Verquvo, Belsomra |
| Novo Nordisk INC | $43.62 | 2021 | |
| Shield Therapeutics INC | $39.29 | 2023-2024 | Accrufer |
| Amgen INC. | $38.51 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $35.83 | 2025 | Airsupra, Breztri |
| Tempus Ai, INC | $24.32 | 2024 | |
| Corium, LLC | $22.77 | 2023 | Adlarity |
| Horizon Therapeutics Plc | $22.16 | 2021 | |
| Avion Pharmaceuticals | $20.55 | 2022 | |
| Ascensia Diabetes Care US INC. | $20.51 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $19.85 | 2024 | Immunocap |
| Daiichi Sankyo INC. | $19.53 | 2021 | |
| Hologic Sales and Service, LLC | $19.29 | 2023 | Aptima |
| Glaxosmithkline, LLC. | $17.70 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.52 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.50 | 2022 | |
| Medtronic, INC. | $16.17 | 2025 | Inceptiv |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Wade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.